Akihisa Mori

Adenosine A _2A receptor antagonist istradefylline (KW‐6002) reduces “off” time in Parkinson's disease: A double‐blind, randomized, multicenter clinical trial (6002‐US‐005)

Peter A. LeWitt, Mark Guttman, James W. Tetrud et al. · Annals of Neurology · 2008 · 346 citations

Antiparkinsonian effect of a new selective adenosine A_2Areceptor antagonist in MPTP-treated monkeys

Richard Grondin, P.J. Bédard, Abdallah Hadj Tahar et al. · Neurology · 1999 · 247 citations

Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations

Robert A. Hauser, Lisa M. Shulman, Joel M. Trugman et al. · Movement Disorders · 2008 · 203 citations

A 12-week, placebo-controlled study (6002-US-006) of istradefylline in Parkinson disease

Mark Stacy, Dee E. Silver, Tilak Mendis et al. · Neurology · 2008 · 181 citations

The Role of Adenosine A2a Receptors in Regulating Gabaergic Synaptic Transmission in Striatal Medium Spiny Neurons

Akihisa Mori, Tomomi Shindou, Michio Ichimura et al. · Advances in behavioral biology · 1996 · 142 citations · Full text

Synaptic Plasticity, Gabaergic Synaptic Transmission, Neurophysiology +10